Our advice for clinicians on the coronavirus is here.
If you are a member of the public looking for information and advice about coronavirus (COVID-19), including information about the COVID-19 vaccine, go to the NHS website. You can also find guidance and support on the GOV.UK website.
Contents
- Amiodarone for patients within adult services
- Atomoxetine for patients within adult services
- Dexamfetamine for patients within adult services
- Guanfacine for patients within adult services
- Lisdexamfetamine for patients within adult services
- Lithium for patients within adult services
- Methylphenidate in adult services
- Riluzole for patients within adult services
- Azathioprine and mercaptopurine for patients within adult services (non-transplant indications)
- Sulfasalazine for patients within adult services
- Hydroxycarbamide for myeloproliferative disorders and sickle cell disease for patients within adult services
- Hydroxychloroquine for patients within adult services
- Leflunomide for patients within adult services
- Mycophenolate mofetil and mycophenolic acid for patients within adult services (non-transplant indications)
- Ciclosporin (oral) for patients within adult services (non-transplant indications)
- Dronedarone for patients in adult services
- Methotrexate (oral and subcutaneous) for patients in adult services (excluding cancer care)
- Valproate medicines for patients of child-bearing potential – shared care protocol to reflect updated safety advice for all prescribers
Document
Document
Document
Document
Document
Document
Document
Document
Document
Document
Hydroxycarbamide for myeloproliferative disorders and sickle cell disease for patients within adult services
Document
Document
Document
Mycophenolate mofetil and mycophenolic acid for patients within adult services (non-transplant indications)
Document
Document
Document
Document
Valproate medicines for patients of child-bearing potential – shared care protocol to reflect updated safety advice for all prescribers
Document